Page last updated: 2024-08-24

lamivudine and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

lamivudine has been researched along with efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bocchiola, B; Cahua, T; Castagna, A; Danise, A; Galli, L; Gianotti, N; Lazzarin, A; Maillard, M; Panzini, P; Pazzi, A; Salpietro, S; Zandonà, D1
Dorman, E; Peng, S; Rosenblatt, L; Sorensen, S; Tafazzoli, A; Villasis-Keever, A1
Maharaj, N; Moodley, D; Moodley, T; Sartorius, B; Sebitloane, M1
Andany, N; Gold, WL1

Other Studies

4 other study(ies) available for lamivudine and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

ArticleYear
Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
    HIV medicine, 2013, Volume: 14, Issue:3

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Cross-Sectional Studies; Deoxycytidine; Dideoxynucleosides; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Furans; HIV Infections; Humans; Italy; Lamivudine; Male; Medication Adherence; Middle Aged; Nevirapine; Oligopeptides; Organophosphates; Organophosphonates; Oxazines; Pyridines; Self Report; Sulfonamides; Surveys and Questionnaires; Viral Load

2013
Cost-effectiveness of DTG + ABC/3TC versus EFV/TDF/FTC for first-line treatment of HIV-1 in the United States.
    Journal of medical economics, 2015, Volume: 18, Issue:10

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Computer Simulation; Cost-Benefit Analysis; Dideoxynucleosides; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lamivudine; Quality-Adjusted Life Years; United States

2015
Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
    BMC pregnancy and childbirth, 2016, Feb-11, Volume: 16

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prenatal Care; South Africa; Stavudine; Young Adult; Zidovudine

2016
Single-tablet antiretroviral treatment (once daily).
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Sep-20, Volume: 188, Issue:13

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Interactions; Drug Resistance, Viral; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Mental Disorders; Oxazines; Piperazines; Pyridones; Viral Load

2016